Recent advances in the understanding of CD have attracted several treatment approaches for CD, for example, decreasing the immunogenic gluten content in crops [36], introducing digestive enzymes and intra-luminal peptidases [37], inhibition of tTG, blockage of HLA-DQ presentation, and silencing of gluten-reactive T cells [38]. This evidence concerns the gene TGM2 and Cowden disease.